These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6167811)

  • 1. Paradoxical inotropic effects of clonidine and labetalol in the conscious rabbit.
    McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1981; 3(4):818-27. PubMed ID: 6167811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.
    Kenny D; Pagel PS; Warltier DC
    Basic Res Cardiol; 1992; 87(5):465-77. PubMed ID: 1334401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
    Kogure H; Hosaka A; Abiko Y
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):109-22. PubMed ID: 6268004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the rate and force responses to phenylephrine on rat atria with labetalol.
    Simpson WW; McNeill JH
    Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):373-6. PubMed ID: 7414055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the alpha and beta blocking effects of intravenous labetalol on left ventricular function in coronary artery disease.
    Gagnon RM; Presant S; Morissette M
    Can J Cardiol; 1985; 1(4):259-62. PubMed ID: 2996729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of arotinolol, labetalol and propranolol on regional myocardial dysfunction induced by flow-limiting coronary stenosis in anesthetized dogs.
    Noguchi K; Kato T; Kinjo N; Moromizato H; Sakanashi M
    Jpn J Pharmacol; 1990 Jul; 53(3):381-91. PubMed ID: 1697348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labetalol binding to specific alpha- and beta-adrenergic sites in vitro and its antagonism of adrenergic responses in vivo.
    Greenslade FC; Tobia AJ; Madison SM; Krider KM; Newquist KL
    J Mol Cell Cardiol; 1979 Aug; 11(8):803-11. PubMed ID: 226721
    [No Abstract]   [Full Text] [Related]  

  • 9. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
    Dowell RT; Houdi AA
    Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of adimolol, labetalol and propranolol on heart rate and blood pressure in man.
    Riddell JG; Harron DW; Shanks RG
    Br J Clin Pharmacol; 1985 Apr; 19(4):405-10. PubMed ID: 2859871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baroreflex control of myocardial contractility in conscious normotensive and renal hypertensive rabbits.
    Aylward PE; McRitchie RJ; Chalmers JP; West MJ
    Hypertension; 1983; 5(6):916-26. PubMed ID: 6654454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3',5'-adenosine monophosphate.
    Ririe DG; Butterworth JF; Royster RL; MacGregor DA; Zaloga GP
    Anesthesiology; 1995 Apr; 82(4):1004-12. PubMed ID: 7717535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of labetalol and propranolol on blood pressure at rest and during isometric and dynamic exercise.
    Nyberg G; Vedin A; Wilhelmsson C
    Eur J Clin Pharmacol; 1979 Nov; 16(5):299-303. PubMed ID: 520397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the haemodynamic effects of labetalol in man.
    Cohn JN; Mehta J; Francis GS
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction by endogenous noradrenaline of an alpha 1-adrenoceptor-mediated positive inotropic effect in rabbit papillary muscles.
    Hattori Y; Takeda Y; Nakaya H; Kanno M
    Br J Pharmacol; 1993 Aug; 109(4):1232-8. PubMed ID: 8401934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of combined alpha-beta-blockade. I.
    Louis WJ; McNeil JJ; Drummer OH
    Drugs; 1984; 28 Suppl 2():16-34. PubMed ID: 6151889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Dl- and l-propranolol, labetalol, and phentolamine on rabbit iris blood flow determined by hydrogen clearance method.
    Kogure H
    Hokkaido Igaku Zasshi; 1982 Nov; 57(6):679-87. PubMed ID: 7183498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic and metabolic effects of combined adrenergic alpha- and beta-receptor blockade with labetalol in the exercising human forearm.
    Hartling OJ; Svendsen TL; Trap-Jensen J
    Eur J Clin Invest; 1980 Dec; 10(6):431-5. PubMed ID: 6265221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.